Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

  ()
Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. read more >

Chembio Launches COVID-19 Test that Provides Quick Results from a Simple Finger Stick

  ()
Chembio Diagnostics shares traded higher and set a new 52-week high price after the company reported that it has launched a DPP® COVID-19 serological point-of-care test which can deliver IgM/IgG antibody results in 15 minutes using a simple finger stick. read more >

Three COVID-19 Patients Treated with PLX Cells

Research Report
  ()
Two programs, one new and the other ongoing, involving Pluristem Therapeutics' regenerative products are reviewed in a Dawson James report. read more >
News Update

Healthcare Firm Expands Telemedicine App to Ontario as Coronavirus Concerns Accelerate Demand

News Update
  ()
CloudMD reported that it has launched its telemedicine app in Ontario as coronavirus concerns have greatly increased the need for digital healthcare. read more >

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment

  ()
Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. read more >

Abbott Labs Launches Point-of-Care Diagnostic Tool that Can Detect COVID-19 in 5 Minutes

  ()
Shares of Abbott Laboratories opened 11% higher after the company reported that its ID NOW™ molecular point-of-care test to detect novel coronavirus will be available starting this week with plans to quickly ramp up production to deliver 50,000 tests per day. read more >

Eton Pharma Shares Climb 20% After Firm Secures US Rights for Pediatric Kidney Disease Drug

  ()
Shares of Eton Pharmaceuticals traded higher after the company reported that it has acquired U.S. marketing rights to pediatric orphan drug Alkindi® Sprinkle from Diurnal Group Plc. read more >
News Update

Digital Health Firm Expands Its Mobile Platform to Four U.S. States

News Update
  ()
Reliq Health Technologies has entered into an agreement with MedTech Evolutions to provide its iUGO Care platform to over 27,000 patients in Alabama, Illinois, Mississippi and Tennessee. read more >
News Update

Inhaled Nitric Oxide Being Tested as COVID-19 Treatment

News Update
  ()
Nu-Med Plus has two collaborative, Phase 2 clinical trials in progress, which it is diligently monitoring. read more >
News Update

Maker of Antibiotic-Free Animal Supplement Lands First Order from Mexico

News Update
  ()
This new market is a significant one for Avivagen. read more >

Expert Investing Ideas

"DRRX already exceeded enrollment in its Phase 1b NASH trial."

–Francois Brisebois, Craig-Hallum Capital


"DRRX earned a $10M milestone payment from Gilead."

–Ed Arce, H.C. Wainwright & Co.


"The market for DRRX's POSIMIR could be substantial."

–Brian Marckx, Zacks Small-Cap Research


Learn More about Which Online Broker is Right for You?

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical

Coronavirus Propels Telemedicine into the Spotlight

Contributed Opinion
  ()
McAlinden Research Partners takes a look at how telemedicine companies are positioned to profit both during and in the wake of the current pandemic, and offers a couple of options for investors. read more >

Coty Shares Rise 30% After Starting Production of Gel for Hand Sanitizer Use

  ()
Shares of Coty traded higher after the company reported that it has commenced production of hydro-alcoholic gel for use as hand sanitizer to help combat the COVID-19 virus. read more >
News Update

Drone Firm Chosen to Integrate Breakthrough Health Diagnosis Technology in Fight Against Coronavirus

  ()
Draganfly and its partners aim to rapidly deploy the groundbreaking technology so it can help combat COVID-19. read more >

T2 Biosystems Shares Nearly Double on Worldwide COVID-19 Testing License Deal

  ()
Shares of T2 Biosystems Inc. traded 90% higher after the company reported that a new COVID-19 assay licensed from Hackensack Meridian Health's Center for Discovery and Innovation will be adapted to run on its FDA-cleared T2Dx® Instrument. read more >